Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Structure and immunogenicity of a stabilized HIV-1 envelope trimer based on a group-M consensus sequence.

Sliepen K, Han BW, Bontjer I, Mooij P, Garces F, Behrens AJ, Rantalainen K, Kumar S, Sarkar A, Brouwer PJM, Hua Y, Tolazzi M, Schermer E, Torres JL, Ozorowski G, van der Woude P, de la Peña AT, van Breemen MJ, Camacho-Sánchez JM, Burger JA, Medina-Ramírez M, González N, Alcami J, LaBranche C, Scarlatti G, van Gils MJ, Crispin M, Montefiori DC, Ward AB, Koopman G, Moore JP, Shattock RJ, Bogers WM, Wilson IA, Sanders RW.

Nat Commun. 2019 May 29;10(1):2355. doi: 10.1038/s41467-019-10262-5.

2.

Influenza virus infection as well as immunization with DNA encoding haemagglutinin protein induces potent antibody-dependent phagocytosis (ADP) and monocyte infection-enhancing responses in macaques.

Koopman G, Mortier D, Michels S, Hofman S, Fagrouch Z, Remarque EJ, Verschoor EJ, Mooij P, Bogers WMJM.

J Gen Virol. 2019 May;100(5):738-751. doi: 10.1099/jgv.0.001251. Epub 2019 Mar 28.

PMID:
30920368
3.

Needle-free delivery of DNA: Targeting of hemagglutinin to MHC class II molecules protects rhesus macaques against H1N1 influenza.

Mooij P, Grødeland G, Koopman G, Andersen TK, Mortier D, Nieuwenhuis IG, Verschoor EJ, Fagrouch Z, Bogers WM, Bogen B.

Vaccine. 2019 Feb 4;37(6):817-826. doi: 10.1016/j.vaccine.2018.12.049. Epub 2019 Jan 9.

4.

Mini-hemagglutinin vaccination induces cross-reactive antibodies in pre-exposed NHP that protect mice against lethal influenza challenge.

van der Lubbe JEM, Huizingh J, Verspuij JWA, Tettero L, Schmit-Tillemans SPR, Mooij P, Mortier D, Koopman G, Bogers WMJM, Dekking L, Meijberg W, Kwaks T, Brandenburg B, Tolboom JTBM, Schuitemaker H, Roozendaal R, Kuipers H, Zahn RC.

NPJ Vaccines. 2018 Jul 3;3:25. doi: 10.1038/s41541-018-0063-7. eCollection 2018.

5.

Effective role of medium supplementation in microalgal lipid accumulation.

Fazeli Danesh A, Mooij P, Ebrahimi S, Kleerebezem R, van Loosdrecht M.

Biotechnol Bioeng. 2018 May;115(5):1152-1160. doi: 10.1002/bit.26548. Epub 2018 Feb 13.

PMID:
29337346
6.

Increased, Durable B-Cell and ADCC Responses Associated with T-Helper Cell Responses to HIV-1 Envelope in Macaques Vaccinated with gp140 Occluded at the CD4 Receptor Binding Site.

Bogers WMJM, Barnett SW, Oostermeijer H, Nieuwenhuis IG, Beenhakker N, Mortier D, Mooij P, Koopman G, Remarque E, Martin G, Lai RP, Dey AK, Sun Y, Burke B, Ferrari G, Montefiori D, Martin L, Davis D, Srivastava I, Heeney JL.

J Virol. 2017 Sep 12;91(19). pii: e00811-17. doi: 10.1128/JVI.00811-17. Print 2017 Oct 1.

7.

Role of microbial translocation in soluble CD14 up-regulation in HIV-, but not in HCV-, infected chimpanzees.

Verstrepen BE, Nieuwenhuis IG, Mooij P, Verschoor EJ, Fagrouch ZC, Kondova I, Boonstra A, Koopman G.

J Gen Virol. 2016 Oct;97(10):2599-2607. doi: 10.1099/jgv.0.000577. Epub 2016 Aug 16.

PMID:
27534537
8.

Influence of silicate on enrichment of highly productive microalgae from a mixed culture.

Mooij PR, de Jongh LD, van Loosdrecht MC, Kleerebezem R.

J Appl Phycol. 2016;28:1453-1457. Epub 2015 Aug 11.

9.

Spontaneous and natural cytotoxicity receptor-mediated cytotoxicity are effector functions of distinct natural killer subsets in hepatitis C virus-infected chimpanzees.

Verstrepen BE, Nieuwenhuis IG, Mooij P, Bogers WM, Boonstra A, Koopman G.

Clin Exp Immunol. 2016 Jul;185(1):42-9. doi: 10.1111/cei.12774. Epub 2016 Apr 27.

10.

Correlation between Virus Replication and Antibody Responses in Macaques following Infection with Pandemic Influenza A Virus.

Koopman G, Mooij P, Dekking L, Mortier D, Nieuwenhuis IG, van Heteren M, Kuipers H, Remarque EJ, Radošević K, Bogers WM.

J Virol. 2015 Nov 4;90(2):1023-33. doi: 10.1128/JVI.02757-15. Print 2016 Jan 15.

11.

Pandemic Swine-Origin H1N1 Influenza Virus Replicates to Higher Levels and Induces More Fever and Acute Inflammatory Cytokines in Cynomolgus versus Rhesus Monkeys and Can Replicate in Common Marmosets.

Mooij P, Koopman G, Mortier D, van Heteren M, Oostermeijer H, Fagrouch Z, de Laat R, Kobinger G, Li Y, Remarque EJ, Kondova I, Verschoor EJ, Bogers WM.

PLoS One. 2015 May 6;10(5):e0126132. doi: 10.1371/journal.pone.0126132. eCollection 2015.

12.

Synthetic long peptide booster immunization in rhesus macaques primed with replication-competent NYVAC-C-KC induces a balanced CD4/CD8 T-cell and antibody response against the conserved regions of HIV-1.

Mooij P, Koopman G, Drijfhout JW, Nieuwenhuis IG, Beenhakker N, Koestler J, Bogers WM, Wagner R, Esteban M, Pantaleo G, Heeney JL, Jacobs BL, Melief CJ.

J Gen Virol. 2015 Jun;96(Pt 6):1478-83. doi: 10.1099/vir.0.000074. Epub 2015 Feb 9.

PMID:
25667320
13.

Ecology-based selective environments as solution to contamination in microalgal cultivation.

Mooij PR, Stouten GR, van Loosdrecht MC, Kleerebezem R.

Curr Opin Biotechnol. 2015 Jun;33:46-51. doi: 10.1016/j.copbio.2014.11.001. Epub 2014 Nov 20. Review.

PMID:
25445547
14.

Potent immune responses in rhesus macaques induced by nonviral delivery of a self-amplifying RNA vaccine expressing HIV type 1 envelope with a cationic nanoemulsion.

Bogers WM, Oostermeijer H, Mooij P, Koopman G, Verschoor EJ, Davis D, Ulmer JB, Brito LA, Cu Y, Banerjee K, Otten GR, Burke B, Dey A, Heeney JL, Shen X, Tomaras GD, Labranche C, Montefiori DC, Liao HX, Haynes B, Geall AJ, Barnett SW.

J Infect Dis. 2015 Mar 15;211(6):947-55. doi: 10.1093/infdis/jiu522. Epub 2014 Sep 18.

15.

Strong vaccine-induced CD8 T-cell responses have cytolytic function in a chimpanzee clearing HCV infection.

Verstrepen BE, Verschoor EJ, Fagrouch ZC, Mooij P, de Groot NG, Bontrop RE, Bogers WM, Heeney JL, Koopman G.

PLoS One. 2014 Apr 16;9(4):e95103. doi: 10.1371/journal.pone.0095103. eCollection 2014.

16.

DNA/long peptide vaccination against conserved regions of SIV induces partial protection against SIVmac251 challenge.

Koopman G, Beenhakker N, Nieuwenhuis I, Doxiadis G, Mooij P, Drijfhout JW, Koestler J, Hanke T, Fagrouch Z, Verschoor EJ, Bontrop RE, Wagner R, Bogers WM, Melief CJ.

AIDS. 2013 Nov 28;27(18):2841-51. doi: 10.1097/QAD.0000000000000047.

PMID:
24105029
17.

Whole blood stimulation with Toll-like receptor (TLR)-7/8 and TLR-9 agonists induces interleukin-12p40 expression in plasmacytoid dendritic cells in rhesus macaques but not in humans.

Koopman G, Beenhakker N, Burm S, Bouwhuis O, Bajramovic J, Sommandas V, Mudde G, Mooij P, 't Hart BA, Bogers WM.

Clin Exp Immunol. 2013 Oct;174(1):161-71. doi: 10.1111/cei.12155.

18.

Evaluation of IL-28B polymorphisms and serum IP-10 in hepatitis C infected chimpanzees.

Verstrepen BE, de Groot NG, Groothuismink ZM, Verschoor EJ, de Groen RA, Bogers WM, Janssen HL, Mooij P, Bontrop RE, Koopman G, Boonstra A.

PLoS One. 2012;7(10):e46645. doi: 10.1371/journal.pone.0046645. Epub 2012 Oct 30.

19.

Immunization with apoptotic pseudovirus transduced cells induces both cellular and humoral responses: a proof of concept study in macaques.

Koopman G, Beenhakker N, Hofman S, Walther-Jallow L, Mäkitalo B, Mooij P, Anderson J, Verschoor E, Bogers WM, Heeney JL, Spetz AL.

Vaccine. 2012 Mar 28;30(15):2523-34. doi: 10.1016/j.vaccine.2012.01.082. Epub 2012 Feb 5.

PMID:
22314133
20.

No difference in Gag and Env immune-response profiles between vaccinated and non-vaccinated rhesus macaques that control immunodeficiency virus replication.

Nieuwenhuis I, Beenhakker N, Bogers WM, Otting N, Bontrop RE, Dubois P, Mooij P, Heeney JL, Koopman G.

J Gen Virol. 2010 Dec;91(Pt 12):2974-84. doi: 10.1099/vir.0.022772-0. Epub 2010 Sep 8.

PMID:
20826621
21.

Comparison of human and rhesus macaque T-cell responses elicited by boosting with NYVAC encoding human immunodeficiency virus type 1 clade C immunogens.

Mooij P, Balla-Jhagjhoorsingh SS, Beenhakker N, van Haaften P, Baak I, Nieuwenhuis IG, Heidari S, Wolf H, Frachette MJ, Bieler K, Sheppard N, Harari A, Bart PA, Liljeström P, Wagner R, Pantaleo G, Heeney JL.

J Virol. 2009 Jun;83(11):5881-9. doi: 10.1128/JVI.02345-08. Epub 2009 Mar 25.

22.

Systemic neutralizing antibodies induced by long interval mucosally primed systemically boosted immunization correlate with protection from mucosal SHIV challenge.

Bogers WM, Davis D, Baak I, Kan E, Hofman S, Sun Y, Mortier D, Lian Y, Oostermeijer H, Fagrouch Z, Dubbes R, van der Maas M, Mooij P, Koopman G, Verschoor E, Langedijk JP, Zhao J, Brocca-Cofano E, Robert-Guroff M, Srivastava I, Barnett S, Heeney JL.

Virology. 2008 Dec 20;382(2):217-25. doi: 10.1016/j.virol.2008.09.016. Epub 2008 Oct 22.

23.

Improved HIV-1 specific T-cell responses by short-interval DNA tattooing as compared to intramuscular immunization in non-human primates.

Verstrepen BE, Bins AD, Rollier CS, Mooij P, Koopman G, Sheppard NC, Sattentau Q, Wagner R, Wolf H, Schumacher TN, Heeney JL, Haanen JB.

Vaccine. 2008 Jun 19;26(26):3346-51. doi: 10.1016/j.vaccine.2008.03.091. Epub 2008 Apr 21.

PMID:
18467010
24.

Aerosol immunization with NYVAC and MVA vectored vaccines is safe, simple, and immunogenic.

Corbett M, Bogers WM, Heeney JL, Gerber S, Genin C, Didierlaurent A, Oostermeijer H, Dubbes R, Braskamp G, Lerondel S, Gomez CE, Esteban M, Wagner R, Kondova I, Mooij P, Balla-Jhagjhoorsingh S, Beenhakker N, Koopman G, van der Burg S, Kraehenbuhl JP, Le Pape A.

Proc Natl Acad Sci U S A. 2008 Feb 12;105(6):2046-51. doi: 10.1073/pnas.0705191105. Epub 2008 Feb 11.

25.

Differential CD4+ versus CD8+ T-cell responses elicited by different poxvirus-based human immunodeficiency virus type 1 vaccine candidates provide comparable efficacies in primates.

Mooij P, Balla-Jhagjhoorsingh SS, Koopman G, Beenhakker N, van Haaften P, Baak I, Nieuwenhuis IG, Kondova I, Wagner R, Wolf H, Gómez CE, Nájera JL, Jiménez V, Esteban M, Heeney JL.

J Virol. 2008 Mar;82(6):2975-88. doi: 10.1128/JVI.02216-07. Epub 2008 Jan 9.

26.

Long-term persistence of HIV-1 vaccine-induced CD4+CD45RA-CD62L-CCR7- memory T-helper cells.

Balla-Jhagjhoorsingh SS, Koopman G, Mooij P, Koornstra W, McCormack S, Weber J, Pantaleo G, Heeney JL.

AIDS. 2004 Apr 9;18(6):837-48.

PMID:
15060431
27.

Qualitative T-helper responses to multiple viral antigens correlate with vaccine-induced immunity to simian/human immunodeficiency virus infection.

Mooij P, Nieuwenhuis IG, Knoop CJ, Doms RW, Bogers WM, Ten Haaft PJ, Niphuis H, Koornstra W, Bieler K, Köstler J, Morein B, Cafaro A, Ensoli B, Wagner R, Heeney JL.

J Virol. 2004 Apr;78(7):3333-42.

28.

Rational development of prophylactic HIV vaccines based on structural and regulatory proteins.

Mooij P, Heeney JL.

Vaccine. 2001 Nov 12;20(3-4):304-21. Review.

PMID:
11672892
29.

Protection from secondary human immunodeficiency virus type 1 infection in chimpanzees suggests the importance of antigenic boosting and a possible role for cytotoxic T cells.

Balla-Jhagjhoorsingh SS, Mooij P, ten Haaft PJ, Bogers WM, Teeuwsen VJ, Koopman G, Heeney JL.

J Infect Dis. 2001 Jul 15;184(2):136-43. Epub 2001 Jun 8.

PMID:
11424009
30.

Evidence for viral virulence as a predominant factor limiting human immunodeficiency virus vaccine efficacy.

Mooij P, Bogers WM, Oostermeijer H, Koornstra W, Ten Haaft PJ, Verstrepen BE, Van Der Auwera G, Heeney JL.

J Virol. 2000 May;74(9):4017-27.

31.

Efforts to broaden HIV-1-specific immunity by boosting with heterologous peptides or envelope protein and the influence of prior exposure to virus.

Verschoor EJ, Davis D, van Gils M, Koopman G, Mooij P, Oostermeijer H, Haaft PT, Verstrepen B, Rosenwirth B, Morein B, Barnett SW, Heeney JL.

J Med Primatol. 1999 Aug-Oct;28(4-5):224-32.

PMID:
10593489
32.

HIV-1 vaccine-induced immune responses which correlate with protection from SHIV infection: compiled preclinical efficacy data from trials with ten different HIV-1 vaccine candidates.

Heeney J, Akerblom L, Barnett S, Bogers W, Davis D, Fuller D, Koopman G, Lehner T, Mooij P, Morein B, de Giuli Morghen C, Rosenwirth B, Verschoor E, Wagner R, Wolf H.

Immunol Lett. 1999 Mar;66(1-3):189-95.

PMID:
10203054
33.

Differential cytotoxic T-lymphocyte (CTL) responses in HIV-1 immunised sibling chimpanzees with shared MHC haplotypes.

Balla-Jhagjhoorsingh S, Mooij P, Koopman G, Haaksma T, Teeuwsen V, Heeney J, Bontrop R.

Immunol Lett. 1999 Mar;66(1-3):61-7.

PMID:
10203035
34.

Comparison of immunity generated by nucleic acid-, MF59-, and ISCOM-formulated human immunodeficiency virus type 1 vaccines in Rhesus macaques: evidence for viral clearance.

Verschoor EJ, Mooij P, Oostermeijer H, van der Kolk M, ten Haaft P, Verstrepen B, Sun Y, Morein B, Akerblom L, Fuller DH, Barnett SW, Heeney JL.

J Virol. 1999 Apr;73(4):3292-300.

35.

Conserved CTL epitopes shared between HIV-infected human long-term survivors and chimpanzees.

Balla-Jhagjhoorsingh SS, Koopman G, Mooij P, Haaksma TG, Teeuwsen VJ, Bontrop RE, Heeney JL.

J Immunol. 1999 Feb 15;162(4):2308-14.

36.

A clinically relevant HIV-1 subunit vaccine protects rhesus macaques from in vivo passaged simian-human immunodeficiency virus infection.

Mooij P, van der Kolk M, Bogers WM, ten Haaft PJ, Van Der Meide P, Almond N, Stott J, Deschamps M, Labbe D, Momin P, Voss G, Von Hoegen P, Bruck C, Heeney JL.

AIDS. 1998 Mar 26;12(5):F15-22.

PMID:
9543435
37.

Transition of T3-induced monocyte-derived veiled/dendritic cells into macrophage-like cells by lipopolysaccharide.

Delemarre FG, Mooij P, de Haan-Meulman M, Simons PJ, de Wit HJ, Drexhage HA.

Adv Exp Med Biol. 1995;378:57-9. No abstract available.

PMID:
8526144
40.

An excess of dietary iodine accelerates the development of a thyroid-associated lymphoid tissue in autoimmune prone BB rats.

Mooij P, de Wit HJ, Drexhage HA.

Clin Immunol Immunopathol. 1993 Nov;69(2):189-98.

PMID:
8403556
41.

Autoimmune thyroid disease.

Mooij P, Drexhage HA.

Clin Lab Med. 1993 Sep;13(3):683-97. Review.

PMID:
8222582
42.

Iodine deficiency induces thyroid autoimmune reactivity in Wistar rats.

Mooij P, de Wit HJ, Bloot AM, Wilders-Truschnig MM, Drexhage HA.

Endocrinology. 1993 Sep;133(3):1197-204.

PMID:
8103449
43.

Expression of various MHC class II molecules and of intracellular adhesion molecule-1 (ICAM-1) on focal clusters of dendritic cells in iodine deficiency goitres.

Dimal P, Wilders-Truschnig M, Mooij P, Leb G, Eber O, Langsteger W, Hebenstreit J, Beham A, Stiegler C, Dohr G, et al.

Clin Exp Immunol. 1993 Jun;92(3):397-403.

44.

Periconceptional vitamin profiles are not suitable for identifying women at risk for neural tube defects.

Mooij PN, Steegers-Theunissen RP, Thomas CM, Doesburg WH, Eskes TK.

J Nutr. 1993 Feb;123(2):197-203.

PMID:
8429368
45.

Thyroid hormones and their iodinated breakdown products enhance the capability of monocytes to mature into veiled cells. Blocking effects of alpha-GM-CSF.

Mooij P, de Haan-Meulman M, de Wit HJ, Drexhage HA.

Adv Exp Med Biol. 1993;329:633-6. No abstract available.

PMID:
8379438
46.
47.

Interactions between the immune system and the thyroid. Regulatory networks in health and disease.

Mooij P, Drexhage HA.

Thyroidology. 1992 Apr;4(1):45-8. Review.

PMID:
1284333
48.

The effects of oral contraceptives and multivitamin supplementation on serum ferritin and hematological parameters.

Mooij PN, Thomas CM, Doesburg WH, Eskes TK.

Int J Clin Pharmacol Ther Toxicol. 1992 Feb;30(2):57-62.

PMID:
1551747
49.

Intracranial pressure and fetal heart rate in a hydrocephalic fetus during labor.

Mooij PN, Nijhuis JG, Jongsma HW, Menssen JJ.

Eur J Obstet Gynecol Reprod Biol. 1992 Jan 31;43(2):161-5. Review.

PMID:
1563564
50.

Disturbed reproductive performance in extreme folic acid deficient golden hamsters.

Mooij PN, Wouters MG, Thomas CM, Doesburg WH, Eskes TK.

Eur J Obstet Gynecol Reprod Biol. 1992 Jan 9;43(1):71-5.

PMID:
1737612

Supplemental Content

Support Center